Role of risk assessments in viral safety: an FDA perspective

PDA J Pharm Sci Technol. 2014 Jan-Feb;68(1):6-10. doi: 10.5731/pdajpst.2014.00959.

¹ Office of Biotechnology Products, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Bethesda, MD.

No abstract available